JLC acquires BINEX

JLC, a local investment company, said January 21 it has signed a take-over contract with BINEX, a biopharmaceutical firm, to set foot in the domestic pharmaceutical sector.

We strongly believe that the takeover will add growth momentum to BINEX's research capability. We will transform BINEX into more research-oriented pharmaceutical company,'' a JLC official said after the merger announcemen...